Compounds > mifepristone
Page last updated: 2024-08-23

mifepristone and Bone Cancer

mifepristone has been researched along with Bone Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Check, D; Check, JH; Poretta, T; Wilson, C1
Kucuk, O; Li, X; Mamouni, K; Wu, D; Yang, Y1
Kidani, T; Mashima, N; Masuno, H; Miyazaki, T; Sakayama, K; Yamamoto, H1

Other Studies

3 other study(ies) available for mifepristone and Bone Cancer

ArticleYear
Palliative Benefits of Oral Mifepristone for the Treatment of Metastatic Fibroblastic Osteosarcoma.
    Anticancer research, 2021, Volume: 41, Issue:4

    Topics: Administration, Oral; Bone Neoplasms; Cancer Pain; Humans; Male; Middle Aged; Mifepristone; Neoplasm Metastasis; Osteosarcoma; Palliative Care; Quality of Life; Tibia; Treatment Outcome

2021
Mifepristone Has Limited Activity to Enhance the
    Anticancer research, 2017, Volume: 37, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Bone Neoplasms; Cell Proliferation; Docetaxel; Hormone Antagonists; Humans; Male; Mice; Mifepristone; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Taxoids; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2017
Effect of cortisol on cell proliferation and the expression of lipoprotein lipase and vascular endothelial growth factor in a human osteosarcoma cell line.
    Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:3

    Topics: Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA Replication; Hormone Antagonists; Humans; Hydrocortisone; Immunohistochemistry; Lipoprotein Lipase; Mifepristone; Osteosarcoma; Thymidine; Vascular Endothelial Growth Factor A

2008